Edward Miller
Consigliere Generale presso ALLOVIR, INC.
Patrimonio netto: 384 518 $ in data 31/05/2024
Posizioni attive di Edward Miller
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALLOVIR, INC. | Consigliere Generale | 01/01/2019 | - |
| Segretario Aziendale | 01/01/2019 | - |
Storia della carriera di Edward Miller
Precedenti posizioni note di Edward Miller
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Responsabile della Conformità | 17/09/2014 | 01/05/2017 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Consigliere Generale | 01/01/2000 | 01/01/2014 |
| ELOXX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - | - |
| Direttore Finanziario/CFO | - | - |
Formazione di Edward Miller
| Princeton University | Undergraduate Degree |
| Rutgers Law School | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| General Counsel | 2 |
| Compliance Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Borsa valori
- Insiders
- Edward Miller
- Esperienza
